CENTOGENE Collaborates on Research Published in Science Showing Immunopathological Landscape of ...

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Feb. 29, 2024 (GLOBE NEWSWIRE) -- CENTOGENE N.V. (Nasdaq: CNTG) (the “Company”), the essential life science partner for data-driven answers in rare and

Related Keywords

Peter Bauer ,Bayern ,Germany ,Cambridge ,Cambridgeshire ,United Kingdom ,Berlin ,Christian Beetz ,Christian Ganoza ,Melissa Hall ,Jean Laurent Casanova ,Lennart Streibel ,Laboratory Of Human Genetics Infectious Diseases ,Drug Administration ,Exchange Commission ,Linkedin ,Corporate Communications ,Human Genetics ,Infectious Diseases ,Institut Imagine ,South Asia ,Middle East ,Chief Medical ,Genomic Officer ,Rare Disease Day ,Senior Director Genomic Innovation ,Senior Scientist Genomic Innovation ,Insight Reports ,